Nicolas Robalin
Research Subjects
Research Interests
Nicolas Robalin has a total of 7 co-authors. Here are the top co-authors by number of shared publications:
- Eduardo Eyras
EMBL Australia Partner Laboratory Network at the Australian National University, Canberra, ACT 2601, Australia
1 shared publication - Hossein Shenasa
RNA Bioscience Initiative, Department of Biochemistry and Molecular Genetics, University of Colorado School of Medicine
1 shared publication - Matias Montes
Center for Childhood Cancer Research, Abigail Wexner Research Institute, Nationwide Children’s Hospital, Columbus, OH 43205, USA
1 shared publication - Nicole M. Martinez
Department of Chemical and Systems Biology, Stanford University, Stanford, CA 94305, USA; Department of Developmental Biology, Stanford University, Stanford, CA 94305, USA; Sarafan ChEM-H Institute, Stanford University, Stanford, CA 94305, USA; Chan Zuckerberg Biohub, San Francisco, CA 94158, USA
1 shared publication - Rebecca Rodell
Depart-ment of Pathology and Immunology and Department of Medicine, Center for Genome Integrity, Washington University in St. Louis School of Medi-cine, St. Louis, Missouri
1 shared publication Ronit Jain
1 shared publication
Latest Publications
- Open Access
Nano-Mod-Amp reveals RNA sequence, structural and cell type specific features of pseudouridylation by PUS7
Pseudouridines are abundant mRNA modifications that can impact splicing, translation, and stability to tune gene expression. PUS7 is one of the major mRNA pseudouridine synthase whose dysregulation leads to neurodevelopmental disorders and cancer, underscoring the critical function of PUS7-dependent pseudouridines. Beyond a short and degenerate consensus sequence, the molecular mechanisms underlying PUS7-mediated pseudouridylation remain unknown. A lack of targeted, high-throughput pseudouridine detection methods limits simultaneous interrogation of PUS7 regulatory features across many experimental conditions. We developed novel Nanopore sequencing tools, including Nano-Mod-Amp, to reveal pseudouridine stoichiometry, its RNA structural context, and dependence on PUS7 levels at specific sites across biological conditions. We identified a novel RNA structural signature that is associated with more efficient mRNA modification by PUS7. Pseudouridines are largely responsive to modulations in PUS7 protein levels, demonstrating the regulatory potential of varying PUS7 levels across cellular conditions. Conversely, PUS7 activity is also regulated in a cell-type specific manner, independent of PUS7 expression levels in a manner consistent with regulation by RNA structure and RNA binding proteins. Together, we developed Nanopore sequencing tools and uncovered new mechanisms of PUS7 regulation with a framework that can be applied to other RNA-modifying enzymes to query the regulation of the epitranscriptome. Highlights: Nanopore direct RNA sequencing identifies PUS7-dependent pseudouridines with stoichiometry. Nano-Mod-Amp quantifies PUS7-dependent pseudouridines at hundreds of sites in high-throughput. MPRAs define RNA sequence and structural features associated with modification by PUS7. Individual PUS7 target pseudouridines are substoichiometric and poised for regulation. PUS7 activity is regulated by cell type in the absence of differences in PUS7 protein levels.
Open AccessNano-Mod-Amp reveals RNA sequence, structural and cell type specific features of pseudouridylation by PUS7
Pseudouridines are abundant mRNA modifications that can impact splicing, translation, and stability to tune gene expression. PUS7 is one of the major mRNA pseudouridine synthase whose dysregulation leads to neurodevelopmental disorders and cancer, underscoring the critical function of PUS7-dependent pseudouridines. Beyond a short and degenerate consensus sequence, the molecular mechanisms underlying PUS7-mediated pseudouridylation remain unknown. A lack of targeted, high-throughput pseudouridine detection methods limits simultaneous interrogation of PUS7 regulatory features across many experimental conditions. We developed novel Nanopore sequencing tools, including Nano-Mod-Amp, to reveal pseudouridine stoichiometry, its RNA structural context, and dependence on PUS7 levels at specific sites across biological conditions. We identified a novel RNA structural signature that is associated with more efficient mRNA modification by PUS7. Pseudouridines are largely responsive to modulations in PUS7 protein levels, demonstrating the regulatory potential of varying PUS7 levels across cellular conditions. Conversely, PUS7 activity is also regulated in a cell-type specific manner, independent of PUS7 expression levels in a manner consistent with regulation by RNA structure and RNA binding proteins. Together, we developed Nanopore sequencing tools and uncovered new mechanisms of PUS7 regulation with a framework that can be applied to other RNA-modifying enzymes to query the regulation of the epitranscriptome. Highlights: Nanopore direct RNA sequencing identifies PUS7-dependent pseudouridines with stoichiometry. Nano-Mod-Amp quantifies PUS7-dependent pseudouridines at hundreds of sites in high-throughput. MPRAs define RNA sequence and structural features associated with modification by PUS7. Individual PUS7 target pseudouridines are substoichiometric and poised for regulation. PUS7 activity is regulated by cell type in the absence of differences in PUS7 protein levels.